Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Mycobacteria and the Moggie
Ruth Gostelow
Ruth Gostelow
Up to 10 per cent of the UK feline population may show evidence of contact with this group of bacteria

"Cats can be infected by a whole range of mycobacteria," Ruth Gostelow from the Royal Veterinary College, London, told delegates at the BVNA Congress in Telford on Saturday 11 October.

Mycobacteria are a very large group of bacteria, some of which are highly pathogenic. They have a very thick, fatty cell wall that means that they are resistant to environmental factors and can survive in soil and in immune cells in the host. They can also continue to multiply in tissue to form tubercles.

TB and leprosy are mycobacterial diseases that have infected humans for millennia. Mycobacteria were first isolated from cats over 50 years ago and up to 10 per cent of the UK feline population may show evidence of contact with this group of bacteria.

There has been a recent report of M bovis infection in seven cats in Berkshire with evidence that they had transmitted the disease to some of the human owners.

There are three groups of mycobacterial infection in cats – the TB Complex, Non-TB and Feline Leprosy Groups. The source of infection in the first group is either unpasteurised milk or infected rodent prey species, in the second group infection is usually manifested as skin lesions as a result of wound contamination from the environment, and group three infections follow contact with rodents and environmental sources.

How much of a risk do infected cats pose to people? Potentially, the most zoonotic risk is from cats infected with mycobacteria from the TB Complex group, including M bovis. This risk to humans is low, with few reported cases; but it is important to remember that TB is a notifiable disease.

The most likely cats to be infected are males, living in the South West, that go out and hunt and, therefore, have greatest exposure to vector species and environmental sources. Immune-compromised cats are also at risk.

Diagnosis is difficult and initially based on geographical location, lifestyle of the cat and imaging. If there are lesions, then smears and biopsies may be useful, together with microscopic granulomatous changes and specialist staining. Confirmation of the mycobacterial species ultimately requires complex diagnostic tests, and mycobacterial culture is a prudent measure in order to determine antibiotic sensitivity.

Treatment can be challenging and the zoonotic risk is of paramount concern, especially if owners are susceptible – HIV patients, for instance. Therapy may be for an indefinite period, possibly life-long, and costly. It may involve a multi-antibiotic approach and there are often side effects, so compliance and cost are major considerations.

Overall, the outlook for affected cats is highly variable, with the best prognosis in cats with localised skin lesions that can be removed surgically. It should be made very clear to owners that treatment will be costly, time-consuming and of uncertain outcome. In the event that euthanasia is considered, then the body should be cremated.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.